(Q34357570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Resveratrol in metabolic health: an overview of the current evidence and perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

Jens Otto Lunde Jørgensen

5 March 2020

author

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Niels Jessen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Bjørn Richelsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Bjørn Richelsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Steen B. Pedersen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Morten Møller Poulsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

1 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

1290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

74-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

Sirtuin activators and inhibitors

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Are sirtuins viable targets for improving healthspan and lifespan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol inhibits nonalcoholic fatty liver disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Challenges of translating basic research into therapeutics: resveratrol as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

Comparison of treatment effects between animal experiments and clinical trials: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12141

21 January 2018

Identifiers

DOI

10.1111/NYAS.12141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23855468%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference